Aliases: | CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR |
---|---|
Other: | tumor necrosis factor receptor superfamily member 16|NGF receptor|TNFR superfamily, member 16|low affinity neurotrophin receptor p75NTR|low-affinity nerve growth factor receptor|p75 ICD |
Nerve growth factor receptor contains an extracellular domain containing four 40-amino acid repeats with 6 cysteine residues at conserved positions followed by a serine/threonine-rich region, a single transmembrane domain, and a 155-amino acid cytoplasmic domain. The cysteine-rich region contains the nerve growth factor binding domain. [provided by RefSeq, Jul 2008]
VioBright FITC
Common Laser: | 488 |
---|---|
Common Filter: | 525/50 |
Excitation Peak: | 496 |
Emission Peak: | 522 |
Vio®Bright FITC has an excitation peak at 496 nm and an emission peak at 522 nm. It is recommended for use in flow cytometry and fluorescence microscopy.
Popular NGF Receptor p75 VioBright FITC Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Miltenyi Biotec 130-104-847 |
FC | NGF Receptor p75 Non-Human Primate,Human,Other |
Mouse IgG1 κ ME20.4-1.H4 |
100 Tests $345 |
Details | |
Miltenyi Biotec 130-110-115 |
FC | NGF Receptor p75 Mouse,Human |
Human IgG1 REA648 |
30 tests in 300 µL $158 |
Details | |
Miltenyi Biotec 130-113-985 |
FC | NGF Receptor p75 Human |
Mouse IgG1 κ ME20.4-1.H4 |
30 tests in 60 µL $162 |
Details | |
Miltenyi Biotec 130-113-423 |
FC | NGF Receptor p75 Human |
Mouse IgG1 κ ME20.4-1.H4 |
100 tests in 200 µL $405 |
Details | |
Miltenyi Biotec 130-110-081 |
FC | NGF Receptor p75 Human,Mouse |
recombinant human IgG1 REA648 |
100 Tests $355 |
Details | |
Miltenyi Biotec 130-104-893 |
FC | NGF Receptor p75 Non-Human Primate,Human,Other |
Mouse IgG1 κ ME20.4-1.H4 |
30 Tests $138 |
Details | |
Miltenyi Biotec 130-125-199 |
FC | NGF Receptor p75 Human,Mouse |
Human IgG1 REA648 |
100 tests in 200 µL $360 |
Details | |
Browse NGF Receptor p75 / VioBright FITC antibodies. |